A detailed history of Qrg Capital Management, Inc. transactions in Moderna, Inc. stock. As of the latest transaction made, Qrg Capital Management, Inc. holds 35,827 shares of MRNA stock, worth $2.36 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
35,827
Previous 36,535 1.94%
Holding current value
$2.36 Million
Previous $3.89 Billion 9.28%
% of portfolio
0.05%
Previous 0.05%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 12, 2024

SELL
$101.21 - $166.61 $71,656 - $117,959
-708 Reduced 1.94%
35,827 $4.25 Billion
Q1 2024

May 07, 2024

SELL
$85.37 - $115.44 $2.41 Million - $3.26 Million
-28,220 Reduced 43.58%
36,535 $3.89 Billion
Q4 2023

Feb 07, 2024

BUY
$69.51 - $104.43 $46,710 - $70,176
672 Added 1.05%
64,755 $6.44 Billion
Q3 2023

Nov 13, 2023

BUY
$96.41 - $126.61 $6.18 Million - $8.11 Million
64,083 New
64,083 $6.62 Billion

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $25.7B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Qrg Capital Management, Inc. Portfolio

Follow Qrg Capital Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Qrg Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Qrg Capital Management, Inc. with notifications on news.